Exploratory analysis of oral glibenclamide in acute ischemic stroke.
Kaibin HuangYanhong HuYongming WuZhong JiShengnan WangZhenzhou LinJiawei XuSu-Yue PanPublished in: Acta neurologica Scandinavica (2019)
In this study, oral GBC is safe in treating acute hemispheric infarction and might have potential in preventing brain edema and consequential severe disability and death. An adequately powered and randomized trial is warranted.